Verici Dx plc (LON:VRCI – Get Free Report)’s share price was up 22.9% during mid-day trading on Tuesday . The company traded as high as GBX 1.69 ($0.02) and last traded at GBX 1.69 ($0.02). Approximately 337,446 shares changed hands during trading, a decline of 67% from the average daily volume of 1,026,578 shares. The stock had previously closed at GBX 1.38 ($0.02).
Verici Dx Trading Up 7.7%
The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The company has a market cap of £5.31 million, a price-to-earnings ratio of -1.01 and a beta of 1.59. The firm’s 50-day moving average price is GBX 1.63 and its 200 day moving average price is GBX 2.71.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- What Are Earnings Reports?
- 3 Utilities Stocks With Big Earnings, Balanced Risk
- How to Use the MarketBeat Dividend Calculator
- NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise
- How to Calculate Stock Profit
- Intuit’s AI Boom: Stock Soaring, But Should Investors Hit Pause?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
